 |
 |
|
|
RESÚMENES OCTUBRE 2005 |
Basic Neuroscience & Pharmacology
(Requiere estar conectado a internet. Haga un click en la
información del journal)
Haplotype-Based
Linkage of Tryptophan Hydroxylase 2 to Suicide Attempt, Major Depression, and
Cerebrospinal Fluid 5-Hydroxyindoleacetic Acid in 4 Populations
Zhifeng
Zhou, Alec Roy, Robert Lipsky, Kavi Kuchipudi, Guanshan Zhu, Julie Taubman,
Mary-Anne Enoch, Matti Virkkunen, David Goldman
Arch Gen Psychiatry. 2005;62:1109-1118
Genomewide Linkage Scan in Schizoaffective Disorder. Significant
Evidence for Linkage at 1q42 Close to DISC1, and Suggestive Evidence at 22q11
and 19p13
Marian
L. Hamshere, Phil Bennett, Nigel Williams, Ricardo Segurado, Alastair Cardno,
Nadine Norton, David Lambert, Hywel Williams, George Kirov, Aiden Corvin, Peter
Holmans, Lisa Jones, Ian Jones, Michael Gill, Michael C. O’Donovan, Michael J.
Owen, Nick Craddock
Arch Gen Psychiatry. 2005;62:1081-1088
Relationship Between a High-Risk Haplotype in the DTNBP1 (Dysbindin) Gene and Clinical Features of Schizophrenia
Ayman H. Fanous, Edwin J. van den Oord, Brien P. Riley, Steven H.
Aggen, Michael C. Neale, F. Anthony O’Neill, Dermot Walsh, and Kenneth S.
Kendler
Am J Psychiatry
162:1824-1832, October 2005
Nicola J Allen and
Ben A Barres
Current Opinion in Neurobiology. Volume 15, Issue 5,
October 2005, Pages 542-548
Dopaminergic Abnormalities in Select Thalamic Nuclei in Schizophrenia: Involvement of the Intracellular Signal Integrating Proteins Calcyon and Spinophilin
Sarah M. Clinton, Hisham M. Ibrahim, Kirk A. Frey, Kenneth L. Davis,
Vahram Haroutunian, and James H. Meador-Woodruff
Am J Psychiatry
162:1859-1871, October 2005
METABOTROPIC
GLUTAMATE RECEPTORS IN THE BASAL GANGLIA MOTOR CIRCUIT
Nature Reviews Neuroscience 6, 787-798 (2005)
WHAT
MAKES US TICK? FUNCTIONAL AND NEURAL MECHANISMS OF INTERVAL TIMING
Nature Reviews Neuroscience 6, 755-765 (2005)
THE NEURAL BASIS OF HUMAN MORAL
COGNITION
Nature Reviews Neuroscience 6, 799-809 (2005)
Long-term
citalopram administration reduces responsiveness of HPA axis in patients with
major depression: relationship with S-citalopram concentrations in plasma and
cerebrospinal fluid (CSF) and clinical response
Nikisch G, Mathe AA,
Czernik A, Thiele J, Bohner J, Eap CB, Agren H, Baumann P
Psychopharmacology (Berl). 2005 Oct;181(4):751-60.
Epub 2005 Sep 29
Barbara Calabrese
and Shelley Halpain
Neuron.
Volume 48, Issue 1, 6 October 2005, Pages 77-90
Jim J Hagan, Declan N C Jones
Schizophrenia Bulletin 2005 31(4):830-853
Antidepressant-like effects of Trichilia catigua (Catuaba) extract: evidence
for dopaminergic-mediated mechanisms
Maria M. Campos,
Elizabeth S. Fernandes, Juliano Ferreira,
Adair R. S. Santos and João B. Calixto
Psychopharmacology 2005; Volume 182, Number 1: 45
- 53
The pathogenesis
of clinical depression: Stressor- and cytokine-induced alterations of
neuroplasticity
S. Hayley, M.O.
Poulter, Z. Merali and H. Anisman
Neuroscience. Volume 135, Issue 3, 2005, Pages 659-678
Olivier Pascual,
Kristen B. Casper, Cathryn Kubera, Jing Zhang, Raquel Revilla-Sanchez, Jai-Yoon
Sul, Hajime Takano, Stephen J. Moss, Ken McCarthy, Philip G. Haydon
SCIENCE VOL 310; 7 OCTOBER 2005:113-116
DOPAMINE D4 RECEPTOR GENE EXON III POLYMORPHISM AND
INTERINDIVIDUAL VARIATION IN RESPONSE TO CLOZAPINE
AI-LING ZHAO,
JING-PING ZHAO, YU-HU ZHANG, ZHI-MIN XUE, JIN-DONG CHEN, XIAO-GANG CHEN
International Journal of Neuroscience; Volume 115,
Number 11 / November 2005: 1539 - 1547
Mood-
and restraint-based antecedents to binge episodes in bulimia nervosa: possible
influences of the serotonin system
Steiger H, Gauvin L,
Engelberg MJ, Ying Kin NM, Israel M, Wonderlich SA, Richardson J
Psychol Med. 2005 Nov;35(11):1553-62
A positron emission tomography study of the effects of treatment with
valproate on brain 5-HT2A receptors in acute mania
Yatham LN, Liddle PF, Lam RW, Adam MJ, Solomons K,
Chinnapalli M, Ruth TJ
Bipolar Disord 2005: 7 (Suppl. 5): 53
Dynamics of
beta-arrestin1 protein and mRNA levels elevation by antidepressants in
mononuclear leukocytes of patients with depression
A. Matuzany-Ruban,
S. Avissar and G. Schreiber
Journal
of Affective Disorders. Volume 88, Issue 3, November 2005, Pages 307-312
Male elderly
subthreshold depression patients have smaller volume of medial part of
prefrontal cortex and precentral gyrus compared with age-matched normal
subjects: A voxel-based morphometry
Yasuyuki Taki,
Shigeo Kinomura, Shuichi Awata, Kentaro Inoue, Kazunori Sato, Hiroshi Ito, Ryoi
Goto, Shinya Uchida, Ichiro Tsuji, Hiroyuki Arai, Ryuta Kawashima and Hiroshi
Fukuda
Journal
of Affective Disorders. Volume 88, Issue 3, November 2005, Pages 313-320
Serotonin and
dopamine transporter imaging in patients with obsessive–compulsive disorder
Swen Hesse, Ulrich
Müller, Thomas Lincke, Henryk Barthel, Thomas Villmann, Matthias C. Angermeyer,
Osama Sabri and Katarina Stengler-Wenzke
Psychiatry Research: Neuroimaging. Volume 140, Issue
1, 30 October 2005, Pages 63-72
The
role of CRF receptors in anxiety and depression: Implications of the novel CRF1
agonist cortagine
Cedomir Todorovic,
Olaf Jahn, Hossein Tezval, Cathrin Hippel and Joachim Spiess
Neuroscience & Biobehavioral Reviews. Volume 29,
Issue 8, 2005, Pages 1323-1333
Andrew Holmes, Anne
Marie le Guisquet, Elise Vogel, Rachel A. Millstein, Samuel Leman and Catherine
Belzung
Neuroscience &
Biobehavioral Reviews. Volume 29, Issue 8, 2005, Pages 1335-1346
Kentarou Ushijima, Hiromi Sakaguchi, Yuki Sato, Hideto To, Satoru
Koyanagi, Shun Higuchi, and Shigehiro Ohdo
Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity
Richard H. P. Porter, Georg Jaeschke, Will Spooren, Theresa M. Ballard,
Bernd Büttelmann, Sabine Kolczewski, Jens-Uwe Peters, Eric Prinssen, Jürgen
Wichmann, Eric Vieira, Andreas Mühlemann, Silvia Gatti, Vincent Mutel, and Pari
Malherbe
Measurement of Brain Metabolites by 1H Magnetic
Resonance Spectroscopy in Patients with Schizophrenia: A Systematic Review and
Meta-Analysis
R Grant Steen, Robert M Hamer and
Jeffrey A Lieberman
Neuropsychopharmacology (2005) 30, 1949-1962
Neurochemical, Electrophysiological and Pharmacological
Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a
Potential New Type of Antipsychotic
Ronan Depoortère, Gihad
Dargazanli, Genevieve Estenne-Bouhtou, Annick Coste, Christophe Lanneau,
Christophe Desvignes, Martine Poncelet, Michel Heaulme, Vincent Santucci,
Michel Decobert, Annie Cudennec, Carolle Voltz, Denis Boulay, Jean Paul
Terranova, Jeanne Stemmelin, Pierre Roger, Benoit Marabout, Mireille Sevrin,
Xavier Vigé, Bruno Biton, Régis Steinberg, Dominique Françon, Richard Alonso,
Patrick Avenet, Florence Oury-Donat, Ghislaine Perrault, Guy Griebel, Pascal
George, Philippe Soubrié and Bernard Scatton
Neuropsychopharmacology (2005) 30, 1963-1985
N-Desmethylclozapine, a Major Metabolite of Clozapine,
Increases Cortical Acetylcholine and Dopamine Release In Vivo Via Stimulation
of M1 Muscarinic Receptors
Zhu Li, Mei Huang, Junji Ichikawa,
Jin Dai and Herbert Y Meltzer
Neuropsychopharmacology (2005) 30, 1986-1995
Disruption of the Prepulse Inhibition of the Startle Reflex
in Vasopressin V1b Receptor Knockout Mice: Reversal by Antipsychotic Drugs
Nobuaki Egashira, Akito Tanoue,
Fuminori Higashihara, Hiroko Fuchigami, Kazunori Sano, Kenichi Mishima,
Yoshihiko Fukue, Hiroshi Nagai, Yukio Takano, Gozoh Tsujimoto, Jeanne
Stemmelin, Guy Griebel, Katsunori Iwasaki, Tomoaki Ikeda, Ryoji Nishimura and
Michihiro Fujiwara
Neuropsychopharmacology (2005) 30, 1996-2005
Decrease in the AP-2 DNA-Binding Activity and in the Protein
Expression of AP-2
Jagadeesh S Rao, Stanley I
Rapoport and Francesca Bosetti
Neuropsychopharmacology (2005) 30, 2006-2013
Treatment Enhances Ultradian Rhythms of CSF Monoamine
Metabolites in Patients with Major Depressive Episodes
Ronald M Salomon, John S Kennedy,
Benjamin W Johnson, Jennifer Urbano Blackford, Dennis E Schmidt, Joseph
Kwentus, Harry E Gwirtsman, John F Gouda and Richard G Shiavi
Neuropsychopharmacology (2005) 30, 2082-2091
COMT Polymorphisms and Anxiety-Related Personality Traits
Murray B Stein, Margaret Daniele
Fallin, Nicholas J Schork and Joel Gelernter
Neuropsychopharmacology (2005) 30, 2092-2102
Contributions of
the Amygdala to Emotion Processing: From Animal Models to Human Behavior
Elizabeth A. Phelps
and Joseph E. LeDoux
Neuron.
Volume 48, Issue 2, 20 October 2005, Pages 175-187
Serotonin
transporter mutations associated with obsessive-compulsive disorder and
phosphorylation alter binding affinity for inhibitors
Yuan-Wei Zhang and
Gary Rudnick
Neuropharmacology. Volume
49, Issue 6, November 2005, Pages 791-797
Serotonin-transporter
mediated efflux: A pharmacological analysis of amphetamines and
non-amphetamines
Birgit Hilber,
Petra Scholze, Mario M. Dorostkar, Walter Sandtner, Marion Holy, Stefan Boehm,
Ernst A. Singer and Harald H. Sitte
Neuropharmacology. Volume
49, Issue 6, November 2005, Pages 811-819
Kristi S. Rau,
Elisabeth Birdsall, Jarom E. Hanson, Kamisha L. Johnson-Davis, F. Ivy Carroll,
Diana G. Wilkins, James W. Gibb, Glen R. Hanson and Annette E. Fleckenstein
Neuropharmacology. Volume
49, Issue 6, November 2005, Pages 820-830
Larissa
Moutsimilli, Severine Farley, Sylvie Dumas, Salah El Mestikawy, Bruno Giros,
and Eleni T. Tzavara
Neuropharmacology. Volume
49, Issue 6, November 2005, Pages 890-900
L.R. Johnson, C.
Farb, J.H. Morrison, B.S. McEwen and J.E. Ledoux
Neuroscience. Volume 136, Issue 1, 2005, Pages 289-299
Effects
of novel antipsychotics with mixed D2 antagonist/5-HT1A
agonist properties on PCP-induced social interaction deficits in the rat
Liesbeth A. Bruins
Slot, Mark S. Kleven and Adrian Newman-Tancredi
Neuropharmacology. Volume 49, Issue 7, December 2005,
Pages 996-1006
The
antidepressant-like effect of Hypericum caprifoliatum Cham & Schlecht
(Guttiferae) on forced swimming test results from an inhibition of neuronal
monoamine uptake
Alice Viana,
Jean-Claude do Rego, Gilsane von Poser, Alexandre Ferraz, Ana Paula Heckler,
Jean Costentin and Stela Maris Kuze Rates
Neuropharmacology. Volume 49, Issue 7, December 2005,
Pages 1042-1052
Theo Hagg
Trends
in Neurosciences. Volume 28, Issue 11, November 2005, Pages 589-595
Variations in
myelin and oligodendrocyte-related gene expression across multiple brain
regions in schizophrenia: A gene ontology study
Pavel Katsel,
Kenneth L. Davis and Vahram Haroutunia
Schizophrenia
Research. Volume 79, Issues 2-3, 15 November 2005, Pages 157-173
The SNAP25 gene
as a susceptibility gene contributing to attention-deficit hyperactivity
disorder
Y Feng, J Crosbie, K Wigg, T Pathare, A Ickowicz,
R Schachar, R Tannock, W Roberts, M Malone, J Swanson,
J L Kennedy and C L Barr